EXSCALE
DEAD

Serial Number

79181904

Owner

Oncodia AB

Filing Date

Nov 30, 2015

Add to watchlist:

No watchlists yet
View on USPTO

EXSCALE Trademark

Serial Number: 79181904 • Registration: 5348149

EXSCALE is a trademark filed by Oncodia AB on November 30, 2015. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 7 (Machinery), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Oncodia AB (2 trademarks)

Knivstagatan 8

Entity Type: 99

Exscale Biospecimen Solutions AB (2 trademarks)

Uppsala Science Park

Entity Type: 99

Trademark Details

Filing Date

November 30, 2015

Registration Date

December 5, 2017

Published for Opposition

September 19, 2017

Cancellation Date

June 21, 2024

Goods & Services

Computer software containing instructions for nucleic acid extraction methods on a robotic platform for use in the field of life science; computer software containing instructions for nucleic acid extraction methods on a robotic platform for use in the field of medicine; computer software containing instructions for nucleic acid extraction methods on a robotic platform for use in the field of diagnostics; computer software containing instructions for nucleic acid extraction methods on a robotic platform for use in biological, medical or diagnostic research; computer software containing instructions for nucleic acid extraction methods on a robotic platform for use in the field of medical science; computer software containing instructions for nucleic acid extraction methods on a robotic platform for use in the field of diagnostic science; robots for use in the field of life science, namely, motorized liquid handling platforms and machines to process biological specimens for laboratory purposes; robots for use in the field of diagnostics, namely, liquid handling workstations for automated biological sample processing for laboratory purposes; robots for use in biological, medical or diagnostic research, namely, liquid handling workstations for automated biological sample processing for laboratory purposes

Robots for use in the field of life science, namely, motorized liquid handling platforms and machines to process biological specimens for industrial purposes; robots for use in the field of diagnostics, namely, liquid handling workstations for automated biological sample processing for industrial purposes; robots for use in biological, medical or diagnostic research, namely, liquid handling workstations for automated biological sample processing for industrial purposes

Pharmaceutical and veterinary preparations, namely, diagnostic kits comprising biological, chemical and diagnostic reagents for medical and veterinary purposes and diagnostic reagent cartridges for nucleic acid extraction, diagnostic agents, preparations and substances for medical and veterinary purposes, medical diagnostic reagent strips for nucleic acid extraction, reagents for genetic analysis for medical, diagnostic and veterinary use

Chemicals for use in industry and science

Medical apparatus and instruments for nucleic acid extraction; genetic testing apparatus and instruments for medical and veterinary purposes; apparatus and instruments for medical analysis, namely, nucleic acid extraction from biological specimens; medical apparatus and instruments for extraction of DNA and RNA in a clinical or diagnostic setting, namely, cancer diagnostics, except for clinical trials

Scientific and technological services and research and design relating thereto, namely, scientific research, analysis, testing and consulting in the field of life science, medicine and diagnostics, except for conducting pharmaceutical clinical trials; design and development of software for use in the field of life science; design and development of software for use in the field of medicine; design and development of software for use in the field of diagnostics; design and development of software for use in biological, medical or diagnostic research; design and development of software for use in the field of medical science; design and development software for use in the field of diagnostic science

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Jun 6, 2025 INNT
GENERIC MADRID TRANSACTION SENT TO IB
May 7, 2025 XXSS
GENERIC MADRID TRANSACTION CREATED
May 7, 2025 XXCR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 21, 2025 INTR
CANCELLED SECTION 71
Jun 21, 2024 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Feb 2, 2024 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 5, 2022 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jul 9, 2021 NREP
CHANGE OF OWNER RECEIVED FROM IB
Oct 31, 2020 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
May 11, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 21, 2018 FICS
FINAL DISPOSITION PROCESSED
Mar 21, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 5, 2018 FICR
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Feb 15, 2018 LIMN
REGISTERED-PRINCIPAL REGISTER
Dec 5, 2017 R.PR
LIMITATION OF GOODS RECEIVED FROM IB
Nov 24, 2017 LIMG
NOTIFICATION PROCESSED BY IB
Nov 17, 2017 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 19, 2017 NPUB
PUBLISHED FOR OPPOSITION
Sep 19, 2017 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 13, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 13, 2017 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 30, 2017 NONP
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Aug 23, 2017 LIMN
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 15, 2017 PREV
ASSIGNED TO LIE
Jul 23, 2017 ALIE
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 21, 2017 OPNX
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 10, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 10, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 10, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 10, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 10, 2017 CNEA
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 5, 2017 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 5, 2017 OPNR
LIMITATION OF GOODS RECEIVED FROM IB
Jun 23, 2017 LIMG
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 26, 2017 GNRN
NON-FINAL ACTION E-MAILED
Apr 26, 2017 GNRT
NON-FINAL ACTION WRITTEN
Apr 26, 2017 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 6, 2017 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Mar 28, 2017 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 3, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 23, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 23, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 23, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 23, 2017 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 24, 2016 GNFN
FINAL REFUSAL E-MAILED
Aug 24, 2016 GNFR
FINAL REFUSAL WRITTEN
Aug 24, 2016 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 2, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 2, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 2, 2016 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 30, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 30, 2016 REAP
REFUSAL PROCESSED BY IB
May 13, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 21, 2016 RFCS
REFUSAL PROCESSED BY MPU
Mar 21, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 20, 2016 RFCR
NON-FINAL ACTION WRITTEN
Mar 19, 2016 CNRT
ASSIGNED TO EXAMINER
Mar 18, 2016 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 13, 2016 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 9, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 4, 2016 REPR